KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Vertex Pharmaceuticals (VRTX) Inventory Average (2016 - 2025)

Vertex Pharmaceuticals has reported Inventory Average over the past 15 years, most recently at $1.7 billion for Q4 2025.

  • Quarterly results put Inventory Average at $1.7 billion for Q4 2025, up 45.0% from a year ago — trailing twelve months through Dec 2025 was $1.7 billion (up 45.0% YoY), and the annual figure for FY2025 was $1.4 billion, up 48.76%.
  • Inventory Average for Q4 2025 was $1.7 billion at Vertex Pharmaceuticals, up from $1.6 billion in the prior quarter.
  • Over the last five years, Inventory Average for VRTX hit a ceiling of $1.7 billion in Q4 2025 and a floor of $289.8 million in Q1 2021.
  • Median Inventory Average over the past 5 years was $607.7 million (2023), compared with a mean of $745.6 million.
  • Biggest five-year swings in Inventory Average: rose 13.88% in 2022 and later soared 70.95% in 2023.
  • Vertex Pharmaceuticals' Inventory Average stood at $343.3 million in 2021, then rose by 23.63% to $424.4 million in 2022, then skyrocketed by 68.18% to $713.8 million in 2023, then skyrocketed by 60.08% to $1.1 billion in 2024, then soared by 45.0% to $1.7 billion in 2025.
  • The last three reported values for Inventory Average were $1.7 billion (Q4 2025), $1.6 billion (Q3 2025), and $1.4 billion (Q2 2025) per Business Quant data.